Michael H. Davidson, Director of BioAge Labs BIOA, has filed 3 purchases and 10 sales on the open market. The latest trade was on 06/10.

MD

MD

Michael H. Davidson

Director

Company

BioAge Labs BIOA

First filing

24/01/03

Trades

41 trades

Buys / sales

3 / 10

12-month net buying

No record

Last trade

06/10

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
NewAmsterdam PharmaNAMS	Open-market sale	03/02	03/02	443,707 sh	$33.25	$14,753,257.75	−71.8%
NewAmsterdam PharmaNAMS	Open-market sale10b5-1 plan	02/24–02/26	02/26	306,293 sh7 trades	$34.53avg.	$10,575,091.2	−63.8%
NewAmsterdam PharmaNAMS	Open-market sale10b5-1 plan	01/07	01/09	11,582 sh	In footnote	No stated value	−3.0%
NewAmsterdam PharmaNAMS	Open-market sale	25/03/26	25/03/28	12,258 sh	In footnote	No stated value	−3.0%
NewAmsterdam PharmaNAMS	Open-market buy	24/08/20	24/08/22	5,000 sh	$16.27	$81,350	+2.4%
Tenax TherapeuticsTENX	Open-market buy	24/08/08	24/08/08	2,500 sh	In footnote	No stated value	+656.2%
NewAmsterdam PharmaNAMS	Open-market buy	24/06/20	24/06/24	5,000 sh	$17.26	$86,300	+2.5%